Operand, which offers AI-powered due diligence tools for PE firms, raised $31M across a seed and a Series A led by Khosla Ventures at a $220M valuation (Lucinda Shen/Axios)
Operand secured $31 million in capital through a combined seed and Series A financing round. The company achieved a $220 million valuation with venture firm Khosla Ventures leading the investments. The platform focuses on developing specialized artificial intelligence tools to assist private equity firms with their due diligence tasks. Additional operational metrics and detailed plans for the capital were not released.
Key points
Private equity workflows are attracting substantial capital investments through specializ…: Private equity workflows are attracting substantial capital investments through specialized artificial intelligence solutions.
Prominent venture capital firms continue to place large valuations on emerging financial…: Prominent venture capital firms continue to place large valuations on emerging financial technology providers.
Operand has officially secured significant institutional backing despite not disclosing s…: Operand has officially secured significant institutional backing despite not disclosing specific future spending plans.
Sources checked by our analysis pipeline: 1
Kierra Frazier / CBS News: |
Alex Fitzpatrick / Axios: |
Myles Miller / Bloomberg: |
Michael Acton / Financial Times: |
Reuters: |
CNBC: |
Wall Street Journal: |
Bruce Gil / Gizmodo: |
@microsoft: |
Ashley Capoot / CNBC: |
Semafor: |
Stephen Witt / New York Times: |
Eduardo Baptista / Reuters: |
Bloomberg: |
Kara Carlson / Bloomberg: |
Alice Tecotzky / Business Insider: |
John Reynolds / Tech.eu: |
Wen Shao / Fortune: |
Greg Bensinger / Reuters: |
Dan Mangan / CNBC: |
Allison Johnson / The Verge: |
Meghan Bobrowsky / Wall Street Journal: |
New York Times: |
This is a Techmeme archive page. It shows how the site appeared at 2:02 AM ET, November 14, 2026.
The most current version of the site as always is available at our home page. To view an earlier snapshot click here and then modify the date indicated.
As autonomous enterprise tools proliferate, developers are increasingly deploying supervisory mechanisms to ensure safe execution. This fresh capital enables the startup to scale systems designed specifically to keep other AI agents operating within secure, authorized operational boundaries.
The infusion of capital will support the company as it scales automation technologies for complex administrative healthcare procedures. By targeting manual burdens in clinical documentation and financial tracking, the platform seeks to modernize critical operational pipelines across the medical sector. This substantial backing highlights ongoing investor confidence in applying artificial intelligence to streamline provider workflows.
The fresh capital will support the company's efforts to advance cloud-based AI infrastructure and specialized software development. By enabling teams to test and execute workloads across diverse hardware chips, the platform helps address flexibility in AI deployment. This infrastructure push aims to streamline model performance evaluation across varying compute environments.